Cardiovascular Risk Factors in Adult Patients with Type II Diabetes in Western Kenya

Authors

  • Barasa M Ambrose Uzima University
  • Cherop Doreen Kampala International University Western Campus
  • G. R. Neel Kampala International University Western Campus
  • Kowanga Kenedy Maseno University
  • Aziz Katabasi King Ceaser University
  • Cedrick IZERE INES-Ruhengeri
  • Jackim. N Kampala International University Western Campus

DOI:

https://doi.org/10.55927/eajmr.v2i6.4347

Keywords:

Metabolic Syndrome, Obesity, Hypertension, Hyperglycemia, Insulin Resistance

Abstract

This study investigates the risk factors associated with cardiovascular disorders among adult patients with type II diabetes in western Kenya. Acrossectional quantitative study was conducted among randomly selected type II diabetic patients aged 18 years and above. Data was collected through questionnaires and medical examination. The study found a high prevalence of obesity, hypertension and dyslipidemia among the participants indicating a significant risk of cardiovascular disorders in this population.

References

Cho, L. (2011). Metabolic syndrome. Singapore Med J, 52(11), 779–785.

Delgado-Lista, J., Perez-Martinez, P., Garcia-Rios, A., Perez-Caballero, A. I., Perez- Jimenez, F., & Lopez-Miranda, J. (2014). Mediterranean Diet and Cardiovascular Risk: Beyond Traditional Risk Factors. Critical Reviews in Food Science and Nutrition, 8398(August 2014), 37–41.

Dumas, M., Kinross, J., & Nicholson, J. K. (2014). Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease. Gastroenterology, 146(1), 46–62.

Fuentes, E., Fuentes, F., Vilahur, G., Badimon, L., & Palomo, I. (2013). Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators of Inflammation, 2013.

Gillingham, L. G., Harris-Janz, S., & Jones, P. J.H. (2011). Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids, 46(3), 209–228.

Grundy, S. M. (2012). Pre-diabetes, metabolic syndrome, and cardiovascular risk. Journal of the American College of Cardiology, 59(7), 635–643.

Grundy, S. M. (2012). Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol, 59(7), 635–643.

Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011). Metabolic syndrome: definitions and controversies. BMC Medicine, 9(1), 48.

Kaur, J. (2014). A comprehensive review on metabolic syndrome. Cardiology Research and Practice.

Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L. (2011). Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Progress in Lipid Research.

Samson, S. L., & Garber, A. J. (2014). Metabolic syndrome. Endocrinology and Metabolism Clinics of North America.

Timar, R., Timar, B., Degeratu, D., Serafinceanu, C., & Oancea, C. (2014). Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus. The Journal of International Medical Research, 42(5), 1131–8.

Vogt, B. P., Souza, P. L., Minicucci, M. F., Martin, L. C., Barretti, P., & Caramori, J. T. (2014). Metabolic Syndrome Criteria As Predictors of Insulin Resistance, Inflammation and Mortality in Chronic Hemodialysis Patients. Metabolic Syndrome and Related Disorders, 12(8), 443–449.

Williams, E. P., Mesidor, M., Winters, K., Dubbert, P. M., & Wyatt, S. B. (2015). Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem. Current Obesity Reports.

Downloads

Published

2023-06-29

How to Cite

Ambrose, B. M. ., Doreen, C. ., G. R. Neel, Kenedy, K. ., Katabasi, A. ., IZERE, C. ., & Jackim. N. (2023). Cardiovascular Risk Factors in Adult Patients with Type II Diabetes in Western Kenya. East Asian Journal of Multidisciplinary Research, 2(6), 2627–2640. https://doi.org/10.55927/eajmr.v2i6.4347

Issue

Section

Articles